NEUARTIGE JNK-HEMMERMOLEKÜLE

European patent · EP2993180 · Deleted

Register entry

Publication number
EP2993180
Application number
EP15002211
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jun 21, 2011
Published
Mar 9, 2016
Granted
Jan 15, 2020
Deleted
Jan 25, 2024
Reason
Annual fee unpaid
IPC classes
C07K 7/06 (2006.01)
C07K 14/47 (2006.01)
G01N 33/53 (2006.01)
Priority
WO PCT/EP2010/003729 21.06.2010
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 25, 2024

    Deleted, fee unpaid

    Published in Swissreg on 25.01.2024

  2. Feb 10, 2023

    Address changed

    Representative
    Riederer Hasler & Partner Patentanwälte AG, Kappelestrasse 15, 9492 Eschen, Liechtenstein → Swisspat Riederer Hasler Patentanwälte AG, Kappelestrasse 17, 9492 Eschen, Liechtenstein

    Published in Swissreg on 10.02.2023

  3. Jul 1, 2022

    Change

    Published in Swissreg on 01.07.2022

  4. Mar 4, 2020

    Agent entered

    Representative
    Riederer Hasler & Partner Patentanwälte AG, Kappelestrasse 15, 9492 Eschen, Liechtenstein

    Published in Swissreg on 04.03.2020

  5. Jan 15, 2020

    Granted

    Published in Swissreg on 15.01.2020

Parties

Holder

Xigen Inflammation Ltd.

Arch. Makariou III 195 Neocleous House, 3030 Limassol, CY

Agent

Swisspat Riederer Hasler Patentanwälte AG

Kappelestrasse 17, 9492 Eschen, LI

Inventor

Bonny, Christophe

1580 Avenches

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.